Skip to main content

Table 1 Patients, characteristics before and after propensity-score matching

From: Prediabetes as a risk factor for new-onset atrial fibrillation: the propensity-score matching cohort analyzed using the Cox regression model coupled with the random survival forest

 

Pre-match

Post-match

 

NGT

N = 18,659

Prediabetes

N = 17,239

Standardized mean difference

p-value

NGT

N = 14,309

Prediabetes

N = 14,309

Standardized mean difference

p-value

Age (yr)

62.8 ± 10.3

65.0 ± 10.1

0.218

 < 0.001

64.3 ± 10.5

64.6 ± 9.9

0.022

 < 0.001

Sex (male)

7639 (40.9)

8463 (49.1)

0.163

 < 0.001

6639 (46.4)

6770 (47.3)

0.018

0.121

BMI (kg/m2)

23.7 ± 3.5

25.1 ± 3.8

0.363

 < 0.001

24.5 ± 3.6

24.8 ± 3.8

0.073

 < 0.001

HTN

3967 (21.3)

4788 (27.8)

0.145

 < 0.001

3505 (24.5)

3716 (26.0)

0.033

0.004

Hyperlipidemia

2771 (14.9)

3388 (19.7)

0.121

 < 0.001

2430 (17.0)

2679 (18.7)

0.044

 < 0.001

CAD

1602 (8.6)

2178 (12.6)

0.122

 < 0.001

1448 (10.1)

1691 (11.8)

0.051

 < 0.001

Gout

196 (1.1)

231 (1.3)

0.025

0.013

160 (1.1)

169 (1.2)

0.006

0.618

COPD

543 (2.9)

600 (3.5)

0.031

0.002

457 (3.2)

479 (3.3)

0.008

0.465

CKD

349 (1.9)

293 (1.7)

-0.013

0.232

254 (1.8)

257 (1.8)

0.002

0.893

PAOD

375 (2.0)

427 (2.5)

0.030

0.003

316 (2.2)

346 (2.4)

0.014

0.238

History of HF

56 (0.3%)

57 (0.3%)

0.005

0.638

41 (0.3%)

53 (0.4%)

0.015

0.215

History of TIA/ischemic stroke

234 (1.3)

283 (1.6)

0.031

0.002

200 (1.4)

213 (1.5)

0.007

0.519

TCHO (mg/dL)

189.3 ± 36.9

186.4 ± 38.2

-0.070

 < 0.001

188.1 ± 37.3

187.6 ± 38.3

0.001

0.030

LDL (mg/dL)

113.5 ± 28.1

112.8 ± 29.7

0.008

0.015

113.7 ± 28.5

113.3 ± 28.5

-0.015

0.004

HDL (mg/dL)

53.9 ± 12.5

49.5 ± 11.8

-0.446

 < 0.001

51.0 ± 10.8

50.4 ± 11.6

-0.053

 < 0.001

TG (mg/dL)

120.8 ± 74.5

141.2 ± 87.2

0.264

 < 0.001

130.9 ± 81.2

138.1 ± 86.2

0.082

 < 0.001

ALT (U/L)

22.9 ± 31.9

25.8 ± 27.4

0.105

 < 0.001

24.3 ± 35.7

25.1 ± 25.9

0.031

0.663

Baseline eGFR (mL/min/1.73 m2)

76.2 ± 24.9

75.8 ± 26.3

-0.012

0.137

75.9 ± 25.2

75.7 ± 25.9

-0.005

0.451

NT-pro-BNP (pg/mL)

1542.4 ± 4120.1

1134.9 ± 3106.4

-0.050

 < 0.001

972.4.6 ± 3436.8

999.8 ± 3496.7

0.008

0.534

LA (cm)

3.6 ± 0.3

3.7 ± 0.3

0.330

 < 0.001

3.6 ± 0.3

3.6 ± 0.3

0.078

 < 0.001

LVEF (%)

51.8 ± 5.4

51.4 ± 3.8

-0.243

 < 0.001

69.5 ± 4.8

68.9 ± 5.0

-0.122

 < 0.001

LV mass (g)

200.9 ± 23.7

210.4 ± 26.3

0.430

 < 0.001

177.3 ± 30.6

181.7 ± 32.2

0.136

0.006

Mean FPG (mg/dL)

90.0 ± 6.9

105.9 ± 9.2

 

 < 0.001

90.4 ± 6.9

105.7 ± 9.0

 

 < 0.001

Mean HbA1c (%)

5.4 ± 0.2

5.9 ± 0.2

 

 < 0.001

5.4 ± 0.2

5.9 ± 0.2

 

 < 0.001

AF/AFL

642 (3.4)

803 (4.7)

 

 < 0.001

535 (3.7)

654 (4.6)

 

 < 0.001

  1. NGT normal glucose test, BMI body mass index, HTN hypertension, CAD coronary artery disease, COPD chronic obstructive pulmonary disease, PAOD peripheral artery disease, CKD chronic kidney disease, PAOD peripheral arterial occlusive disease, TCHO total cholesterol, LDL low-density lipoprotein, HDL high-density lipoprotein, TG triglyceride, ALT alanine aminotransferase, eGFR estimated glomerular filtration rate, HF heart failure, TIA transient ischemic accident, NT-pro-BNP N-terminal pro B type natriuretic peptide, LVEF left ventricular ejection fraction, LA left atrial size, LV mass left ventricle mass, AF atrial fibrillation, AFL atrial flutter
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840